Antidepressant treatments and human aggression

European Journal of Pharmacology

Volumn 526, Issue 1-3, 2005, Pages 218-225

  Bond, Alyson J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Affiliative behaviour; Aggression; Antidepressant; Dominance; Impulse regulation; Negative affect; Personality trait

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMESERGIDE; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; REBOXETINE; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRYPTOPHAN;

AGGRESSION; ANGER; ASSERTIVENESS; BEHAVIOR DISORDER; BORDERLINE STATE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; DRUG MECHANISM; DRUG REEXPOSURE; EXPERIMENT; HUMAN; IMPULSE CONTROL DISORDER; IRRITABILITY; MAJOR DEPRESSION; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; PERSONALITY; PERSONALITY DISORDER; PRIORITY JOURNAL; SINGLE DRUG DOSE; SOCIAL BEHAVIOR; SOCIAL INTERACTION;

AGGRESSION; ANTIDEPRESSIVE AGENTS; FEMALE; HUMANS; MALE; PERSONALITY DISORDERS;

EID: 28544437661     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.09.033     Document Type: Conference Paper

References (56)

1. C. Allgulander, C.R. Cloninger, T.R. Przybeck, and L. Brandt Changes on the temperament and character inventory after paroxetine treatment in volunteers with generalized anxiety disorder Psychopharmacol. Bull. 34 1998 165 166
2. W. Andrews, G. Parker, and E. Barrett The SSRI antidepressants: exploring their "other" possible properties J. Affect. Disord. 49 1998 141 144
3. R.M. Bagby, R.D. Levitan, S.H. Kennedy, A.J. Levitt, and R.T. Joffe Selective alteration of personality in response to noradrenergic and serotonergic antidepressant medication in depressed sample: evidence of non-specificity Psychiatry Res. 86 1999 211 216
4. R. Baumeister, L. Smart, and J. Boden Relation of threatened egotism to violence and aggression: the dark side of high self-esteem Psychol. Rev. 103 1996 5 33
5. L. Berkowitz On the formation and regulation of anger and aggression: a cognitive-neoassociationistic analysis Am. Psychol. 45 1990 494 503
6. J.M. Bjork, D.M. Dougherty, F.G. Moeller, and A.C. Swann Differential behavioral effects of plasma trytophan depletion and loading in aggressive and nonaggressive men Neuropsychopharmacology 22 2000 357 369
7. K.J. Black, and Y.I. Sheline Personality disorder scores improve with effective pharmacotherapy of depression J. Affect. Disord. 43 1997 11 18
8. A.J. Bond Drug-induced behavioural disinhibition: incidence, mechanisms and therapeutic implications CNS Drugs 9 1998 41 57
9. A.J. Bond Neurotransmitters, temperament and social functioning Eur. Neuropsychopharmacol. 11 2001 261 274
10. A.J. Bond, and J. Wingrove The role of serotonin in the modulation of aggression. Studies using tryptophan manipulation M. Martinez Prevention and Control of Aggression and the Impact on its Victims 2001 Kluwer Academic/Plenum Publishers London
11. A.J Bond, J. Wingrove, and D.G. Critchlow Tryptophan depletion increases aggression in women in the premenstrual phase Psychopharmacology 156 2001 477 480
12. A.L. Brody, S. Saxena, L.A. Fairbanks, S. Alborzian, H.A. Demaree, K.M. Maidment, and L.R. Baxter Jr. Personality changes in adult subjects with major depressive disorder or obsessive-compulsive disorder treated with paroxetine J. Clin. Psychiatry 61 2000 349 355
13. D.R. Cherek, S.D. Lane, and C.J. Pietras Effects of chronic paroxetine administration on measures of aggressive and impulsive responses of adult males with a history of conduct disorder Psychopharmacology 159 2002 266 274
14. A.J. Cleare, and A.J. Bond The effect of tryptophan depletion and enhancement on subjective and behavioural aggression in normal male subjects Psychopharmacology 118 1995 72 81
15. C.R. Cloninger, D.M. Svrakic, and T.R. Przybeck A psychobiological model of temperament and character Arch. Gen. Psychiatry 50 1993 975 990
16. E.F. Coccaro, and R.J. Kavoussi Fluoxetine and impulsive aggressive behavior in personality-disordered subjects Arch. Gen. Psychiatry 54 1997 1081 1088
17. E.F. Coccaro, L.J. Siever, K. Owen, and K.L. Davis Serotonergic studies in patients with affective and personality disorders Arch. Gen. Psychiatry 47 1989 587 599
18. J. Cornelius, P.H. Soloff, J. Perel, and R.F. Ulrich A preliminary trial of fluoxetine in refractory borderline patients J. Clin. Psychopharmacol. 11 1991 116 120
19. P.T. Costa Jr., and R.R. McCrae Personality disorders and the five-factor model of personality J. Pers. Disord. 4 1990 362 371
20. P.W. Dimmock, K.M. Wyatt, P.W. Jones, and P.M.S. O'Brien Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review Lancet 356 2000 1131 1136
21. A. Dubini, M. Bosc, and V. Polin Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioning J. Psychopharmacol. 11 Suppl. 4 1997 S17 S23
22. L. Ekselius, and L. Von Knorring Changes in personality traits during treatment with sertraline or citalopram Br. J. Psychiatry 174 1999 444 448
23. E. Eriksson, M.A. Hedberg, B. Andersch, and C. Sundblad The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome Neuropsychopharmacology 12 1985 167 176
24. M. Fava, and J.F. Rosenbaum Anger attacks in depression Depress. Anxiety 8 Suppl. 1 1998 59 63
25. M. Fava, A.F. Rosenbaum, J.A. Fava, M.K. McCarthy, R.J. Steingard, and E. Bouffides Anger attacks in unipolar depression: Part 1. Clinical correlates and response to fluoxetine treatment Am. J. Psychiatry 150 1993 1158 1163
26. C. Gorenstein, V. Gentil, M. Melo, F. Lotufo-Neto, and V. Lauriano Mood improvement in 'normal' volunteers J. Psychopharmacol. 12 1998 246 251
27. M. Hansenne, and M. Ansseau Harm avoidance and serotonin Biol. Psychol. 51 1999 77 81
28. B. Knutson, O.M. Wolkowitz, S.W. Cole, T. Chan, E.A. Moore, R.C. Johnson, J. Terpstra, R.A. Turner, and V.I. Reus Selective alteration of personality and social behavior by serotonergic intervention Am. J. Psychiatry 155 1998 373 379
29. W.J. Livesley Suggestions for a framework for an empirically based classification of personality disorder Can. J. Psychiatry 43 1998 137 147
30. P.J. Markovitz, and S.C. Wagner Venlafaxine in the treatment of borderline personality disorder Psychopharmacol. Bull. 31 1995 773 777
31. P.J. Markovitz, J.R. Calabrese, S.C. Schulz, and H.Y. Meltzer Fluoxetine in the treatment of borderline and schizotypal personality disorders Am. J. Psychiatry 148 1991 1064 1067
32. D.M. Marsh, D.M. Dougherty, G. Moeller, A.C. Swann, and R. Spiga Laboratory-measured aggressive behaviour of women: acute tryptophan depletion and augmentation Neuropsychopharmacology 26 2002 660 671
33. F.G. Moeller, D.M. Dougherty, A.C. Swann, D. Collins, C.M. Davis, and D.R. Cherek Tryptophan depletion and aggressive responding in healthy males Psychopharmacology 126 1996 97 103
34. D.S Moskowitz, G. Pinard, D.C. Zuroff, L. Annable, and S.N. Young The effect of tryptophan on social interaction in everyday life: a placebo-controlled study Neuropsychopharmacology 25 2001 277 289
35. R.T. Mulder, P.L. Joyce, and S.E. Luty The relationship of personality disorders to treatment outcome in depressed outpatients J. Clin. Psychiatry 64 2003 259 264
36. A.S. New, M.S. Buchsbaum, E.A. Hazlett, M. Goodman, H.W. Koenigsberg, J. Lo, L. Iskander, R. Newmark, J. Brand, K. O'Flynn, and L.J. Siever Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression Psychopharmacology 176 2004 451 458
37. S. Nishizawa, C. Benkelfat, S.N. Young, M. Leyton, S. Mzengeza, C. De Montigny, P. Blier, and M. Diksic Differences between males and females in rates of serotonin synthesis in human brain Proc. Natl. Acad. Sci. 94 1997 5308 5313
38. M. Pasquini, A. Picardi, M. Biondi, P. Gaetano, and P. Morosini Relevance of anger and irritability in outpatients with major depressive disorder Psychopathology 37 2004 155 160
39. R.O. Pihl, S.N. Young, P. Harden, S. Plotnick, B. Chamberlain, and F.R. Ervin Acute effect of altered tryptophan levels and alcohol on aggression in normal human males Psychopharmacology 119 1995 353 360
40. M.A. Posternak, and M. Zimmerman Anger and aggression in psychiatric outpatients J. Clin. Psychiatry 63 2002 665 672
41. M.J. Raleigh, M.T. McGuire, G.L. Brammer, D.B. Pollack, and A. Yuwiler Serotonergic mechanisms promote dominance acquisition in adult male vervet monkeys Brain Res. 559 1991 181 190
42. C. Reist, K. Nakamura, E. Sagart, K.N. Sokolski, and K.A. Fujimoto Impulsive aggressive behavior: open-label treatment with citalopram J. Clin. Psychiatry 64 2003 81 85
43. T. Rhinne, W. van den Brink, L. Wouters, and R. van Dyke SSRI treatment of borderline personality disorder: a randomized, placeo-controlled clinical trial for female patients with borderline personality disorder Am. J. Psychiatry 159 2002 1048 2054
44. J. Richter, M. Eisemann, and G. Richter Temperament and character during the course of unipolar depression among inpatients Eur. Arch. Psychiatry Clin. Neurosci. 250 2000 40 47
45. J.F. Rosenbaum, M. Fava, J.A. Pava, and M.K. McCarthy Anger attacks in unipolar depression: II neuroendocrine correlates and changes following fluoxetine treatment Am. J. Psychiatry 150 1993 1164 1168
46. C. Salzman, A.N. Wolfson, A. Schatzberg, J. Looper, R. Henke, M. Albanese, J. Schwartz, and E. Miyawaki Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder J. Clin. Psychopharmacol. 15 1995 23 29
47. P. Soubrié Reconciling the role of central serotonin neurons in human and animal behaviour Behav. Brain Sci. 9 1986 319 364
48. M.R. Spoont Modulatory role of serotonin in neural information processing: implications for human psychopathology Psychol. Bull. 112 1992 330 350
49. G. Stein Physical treatments of the personality disorders Curr. Opin. Psychiatry 7 1994 129 136
50. W.S. Tse, and A.J. Bond Serotonergic involvement in the psycho-social dimension of personality J. Psychopharmacol. 15 2001 195 198
51. W.S. Tse, and A.J. Bond Difference in serotonergic and noradrenergic regulation of human social behaviours Psychopharmacology 159 2002 216 221
52. W.S. Tse, and A.J. Bond Serotonergic intervention affects both social dominance and affiliative behaviour Psychopharmacology 161 2002 324 333
53. W.S. Tse, and A.J. Bond Reboxetine promotes social bonding in healthy volunteers J. Psychopharmacol. 17 2003 65 71
54. S. Tuinier, and W.M.A. Verhoeven Dimensional classification and behavioral pharmacology of personality disorders; a review and hypothesis Eur. Neuropsychopharmacol. 5 1995 135 146
55. M.T. Walsh, and T.G. Dinan Selective serotonin reuptake inhibitors and violence: a review of the available evidence Acta Psychiatr. Scand. 104 2001 84 91
56. P. Willner Animal models of depression: validity and applications Adv. Biochem. Psychopharmacol. 49 1995 19 41